Related Experiment Videos
Update on outcome assessment in rheumatic disorders
E Molenaar1, D van der Heijde, M Boers
1Department of Rheumatology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Current Opinion in Rheumatology
|April 6, 2000
Summary
Outcome assessment in rheumatic disorders is crucial. The Outcome Measures in Rheumatology (OMERACT) 4 conference advanced research on rheumatoid arthritis, ankylosing spondylitis, and systemic lupus erythematosus.
Area of Science:
- Rheumatology
- Clinical Trials
- Outcome Measurement
Background:
- Outcome assessment is increasingly vital in rheumatology.
- The Outcome Measures in Rheumatology (OMERACT) conferences drive research in this area.
- This review focuses on the OMERACT 4 conference findings.
Purpose of the Study:
- To detail the results of the OMERACT 4 conference.
- To review advancements in outcome assessment for rheumatic disorders.
- To present an overview of recent literature on disease activity, quality of life, and imaging measures.
Main Methods:
- Review of OMERACT 4 conference proceedings.
- Analysis of longitudinal/observational studies.
- Literature review on disease activity, quality of life, and imaging measures.
Main Results:
- OMERACT 4 focused on rheumatoid arthritis (response criteria, imaging), ankylosing spondylitis, and systemic lupus erythematosus core sets.
- New instruments and validation steps for various rheumatic disorders were described.
- Recent literature on disease activity, quality of life, and imaging was overviewed.
Conclusions:
- The OMERACT 4 conference significantly contributed to the field of outcome assessment in rheumatology.
- Advancements in measurement instruments and validation were highlighted.
- The review provides a comprehensive update on current practices and future directions.